Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
Ketamine may alleviate depression, pain, and adverse effects associated with opioid treatment, and may thus represent an attractive adjunct therapy for pain management, according to a novel population analysis recently published in Scientific Reports, reported Linda Peckel in the Clinical Pain Advisor.
The 2017 journal article offered that, “Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Adverse Effect Reporting System…patients who received ketamine had significantly lower frequency of reports of depression than patients who took any other combination of drugs for pain. The analysis also revealed that patients who took ketamine had significantly lower frequency of reports of pain and opioid induced side effects, implying ketamine’s potential to act as a beneficial adjunct agent in pain management pharmacotherapy.”
A significant percentage of patients stop taking conventional antidepressants for a variety of reasons (including an intolerance for side effects) even before they can be therapeutic.
Ketamine has also demonstrated exciting potential for those with TRD (treatment resistant depression). Learn if ketamine could be possible solution for your symptoms by contacting our specialists at 770-817-9200.
You Might Also Enjoy...
Sage Therapeutics and Biogen Announce Positive Pivotal Phase 3 Results for Zuranolone, an Investigational Two-Week, Once-Daily Therapeutic Being Evaluated for Major Depressive Disorder.
Pain can be depressing, and depression creates and exacerbates pain. This cycle can be a dangerous one. In fact, people afflicted by chronic pain are three times more likely to develop psychiatric disorders (most often anxiety or mood disorders).
Depression is a mental disorder that both men and women struggle with. However, in the case of men, the disorder can look very differently that it looks in women.
Anyone that has had Chickenpox, even if it was all the way back in childhood, now lives with the risk of experiencing Shingles when they enter their later years. And what does that have to do with Fibromyalgia?!
If you or a loved one are still struggling with depression even on medication, you are not the only one!
Fibromyalgia is painful, difficult to diagnose and has limited treatment options. But there are always new drugs being developed! #Fibro #FibroATL #FibroAlpharetta #FibroOptions